HER2 (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "HER2" in French language version.

refsWebsite

Global rank French rank

low place

7,741^st place

1,626^th place

2,018^th place

4^th place

12^th place

1sciencemag.org

857^th place

208^th place

low place

low place

2,374^th place

298^th place

1aacrjournals.org

8,869^th place

4,895^th place

2,814^th place

1,023^rd place

aacrjournals.org

cancerres.aacrjournals.org

Hickish T, Whitley D, Lin N et al. Use of BIBW 2992, a novel irreversible EGFR/HER1 and HER2 tyrosine kinase inhibitor to treat patients with HER2-positive metastatic breast cancer after failure of treatment with trastuzumab, Cancer Res, 2009;69:Suppl 3:5060-5060

ascopubs.org

jco.ascopubs.org

Press MF, Slamon DJ, Flom KJ et al. Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens, J Clin Oncol, 2002;20:3095-105
Blackwell KL, Burstein HJ, Storniolo AM et al. Randomized study of lapatinib alone or in combination with trastuzumab in women with ErbB2-positive, trastuzumab-refractory metastatic breast cancer, J Clin Oncol, 2010;28:1124-1130
Burstein HJ, Sun Y, Dirix LY et al. Neratinib, an irreversible ErbB receptor tyrosine kinase inhibitor, in patients with advanced ErbB2-positive breast cancer, J Clin Oncol, 2010;28:1301-1307
Baselga J, Gelmon KA, Verma S et al. Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy, J Clin Oncol, 2010;28:1138-1144

cell.com

Franklin MC, Carey KD, Vajdos FF et al. Insights into ErbB signaling from the structure of the ErbB-pertuzumab complex, Cancer Cell, 2004;5:317-328

ensembl.org

May2017.archive.ensembl.org

GRCh38: Ensembl release 89: ENSG00000141736 - Ensembl, May 2017
GRCm38: Ensembl release 89: ENSMUSG00000062312 - Ensembl, May 2017

nejm.org

Slamon DJ, Leyland-Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2, N Engl J Med, 2001;344:783-792

nih.gov

ncbi.nlm.nih.gov

« Publications PubMed pour l'Homme », sur National Center for Biotechnology Information, U.S. National Library of Medicine
« Publications PubMed pour la Souris », sur National Center for Biotechnology Information, U.S. National Library of Medicine

nordiqc.org

« NordiQC - Immunohistochemical Quality Control », sur www.nordiqc.org (consulté le 5 mars 2020)

sciencemag.org

Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL, Human breast cancer: correlation of relapse and survival with amplification of the HER2/neu oncogene, Science, 1987;235:177-82